Cyclacel Pharmaceuticals Inc. buy krebskrebs
Start price
11.08.22
/
50%
€1.44
Target price
11.08.23
€3.00
Performance (%)
-71.01%
End price
12.08.23
€0.42
Summary
This prediction ended on 12.08.23 with a price of €0.42. The BUY prediction by krebskrebs for Cyclacel Pharmaceuticals Inc. performed very badly with a performance of -71.01%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Cyclacel Pharmaceuticals Inc. | - | - | - |
iShares Core DAX® | -0.116% | 1.953% | 14.155% |
iShares Nasdaq 100 | -2.733% | -1.273% | 31.828% |
iShares Nikkei 225® | -1.721% | 3.263% | 12.922% |
iShares S&P 500 | -1.527% | 0.194% | 27.117% |
Comments by krebskrebs for this prediction
In the thread Cyclacel Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 3,0
In the thread Trading Cyclacel Pharmaceuticals Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten